copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Home | GSK US Ben Schwartz, VP of Oncology, shares his 20-year GSK journey, from drug discovery to leading research Addressing Long-Standing Barriers to Adult Immunization Our COiMMUNITY Initiative fosters a systematic, collaborative, and approach to boost vaccinations
Careers | GSK US At GSK, we unite science, technology and talent to get ahead of disease together We aim to positively impact the health of 2 5 billion people by the end of the decade, as a successful, growing company where people can thrive
Locations | GSK US Trade marks are owned by or licensed to the GSK group of companies GSK plc Registered in England and Wales No 3888792 Registered office: 79 New Oxford Street, London United Kingdom WC1A 1DG GSK websites; GSK Global website; Locations selector; Global Behind the science; GSKPro for HCPs; ViiV Healthcare;
Nucala (mepolizumab) approved by US FDA for use in adults with chronic . . . GSK plc (LSE NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately controlled COPD and an eosinophilic phenotype
Contact us - GSK Disaster response - Contact our US Response Center online if you need help accessing your GSK medicines during a natural disaster Patient Assistance Programs - We are committed to helping patients access our medications, and have a long history of providing a range of programs to help them
Products - GSK US In the US, if you are a patient and have questions about our medicines, please contact the GSK Response Center Our product areas Specialty medicines
GSK data at ASCO and EHA showcase latest research and innovation across . . . GSK plc (LSE NYSE: GSK) today announced that new data across the oncology pipeline and portfolio will be presented in more than 60 abstracts at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting (May 30 – June 3) in Chicago, IL and the 30th European Hematology Association (EHA) Congress (June 12 - 15) in Milan, Italy
ViiV Healthcare continues to deliver long-acting injectable HIV . . . GSK plc (LSE NYSE: GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, will be presenting abstracts from its innovative HIV treatment and prevention portfolio and research pipeline at the Conference on Retroviruses and Opportunistic Infections (CROI 2025)
Search jobs | GSK US Life at GSK We are transforming our culture to create an environment where individuals and teams are inspired to be ambitious for patients